DT vaccine

DT vaccine

Vaccinology A diphtheria and tetanus vaccine that does not protect from pertussis; it is reserved for persons with adverse reactions to a DPT shot or a personal or family history of a seizure disorder or brain disease
Mentioned in ?
References in periodicals archive ?
DT vaccine - diphtheria-tetanus toxoid adsorbed inj.
3 micrograms of mercury per dose from Thimerosal; Influenza Virus Vaccine (Fluzone - Aventis Pasteur) 5 mL Vial - 25 micrograms of mercury per dose from Thimerosal; Pediatric DT Vaccine (Aventis Pasteur) 5 mL Vial - 25 micrograms of mercury per dose from Thimerosal.
Another manufacturer quit making diphtheria and tetanus toxoids for pediatric use, leaving only one manufacturer of DT vaccine.
The estimate of efficacy for WHO-defined cases during the main period of follow-up was 72%, and vaccinated infants had significantly milder disease than those who received the DT vaccine and fewer sought medical attention.
The agreement also includes DPT Vaccine Behring, DT Vaccine Behring, RABIPUR and Td Vaccine Behring.
Diphtheria-Tetanus-Pertussis-Poliomelytidas (Pediatric) 29,175 doses of rabies vaccines 16,900 doses, Yellow Fever Vaccine 8,800 doses of vaccines against typhoid capsular Polysaccharide antigen (Vi) 2 550 doses, Cholera Vaccine 1,480 doses of tetanus 37,000 doses of vaccine, pneumococcal vaccine serotype 90 for 23 doses, Vaccine Meningococcal A + C + Y + W135 2 500 doses, DT Vaccine Adult 2,000 doses Vaccine IPV 6 000 doses Vaccine OPV 1 000 doses, 130 doses of measles, 150 Rubella vaccine doses influenza vaccines 24,500 doses
children receive a whole-cell pertussis vaccine in combination with diphtheria-tetanus toxoid, commonly called DTP, at 2, 4 and 6 months of age, with additional doses of either a DTP or DT vaccine with an acellular pertussis component (DTaP) at 12-18 months and before going to school.